MeSH tree: C14.907.137.126.307
In 2018, the World Health Organization (WHO) released the 11th edition of the International Classification of Diseases—a global, standard-setting guideline for how institutions should understand and organize health information. ...
Nov 17, 2025
0
12
A quality improvement program helped reduce "bad cholesterol" (LDL or low-density lipoprotein) levels among military veterans who have heart and blood vessel disease, according to a preliminary late-breaking science presentation ...
Nov 11, 2025
0
9
A specific pattern of proteins in the blood may reflect an increased risk of hereditary atherosclerosis. This is shown in a new study from Karolinska Institutet, examining close relatives of people who had suffered a heart ...
Nov 10, 2025
0
26
New research from Intermountain Health in Salt Lake City finds that patients diagnosed with peripheral arterial disease (PAD) who also have atrial fibrillation (AFib) face a significantly higher risk of major adverse cardiovascular ...
Nov 10, 2025
0
13
Researchers from Mass General Brigham have unveiled the results of a large clinical trial that found that adding the drug evolocumab to patients' treatment significantly reduced the risk of major adverse cardiovascular events ...
Nov 9, 2025
0
58
Fewer than half of young adults with severely high low-density lipoprotein (LDL-C), or "bad" cholesterol, levels start taking a statin within five years of first high LDL-C measurement, according to a study published in Journal ...
Nov 6, 2025
0
11
In the treatment of larger narrowed blood vessels, drug-coated balloon catheters have been shown to deliver lasting and effective outcomes. Their minimally invasive nature makes them a viable alternative to stents. These ...
Nov 5, 2025
0
18
More than 70% of people over 70 years old will one day develop cardiovascular disease, highlighting the need for effective diagnosis, treatment, and care for this population.
Oct 31, 2025
0
19
Rates of leg and foot amputations in Illinois hospitals increased 65% between 2016 and 2023, reports a new Northwestern Medicine study.
Oct 30, 2025
0
11
Building on earlier studies showing its benefits for type 2 diabetes, a new study has revealed the experimental drug IC7Fc may also help prevent heart disease by lowering cholesterol and reducing inflammation.
Oct 28, 2025
0
106
